发明名称 IMPROVED HUMANIZED ANTI-HUMAN 9-INTEGRIN ANTIBODY
摘要 The present invention provides a humanized anti-human ±9 integrin antibody having improved activity and/or property as compared to donor mouse anti-human ±9 integrin antibody, namely, a humanized anti-human ±9 integrin antibody comprising a heavy-chain variable region consisting of the amino acid sequence shown by SEQ ID NO: 1 or the amino acid sequence shown by SEQ ID NO: 1 wherein one or several amino acids are substituted, deleted, inserted and/or added and a light-chain variable region consisting of the amino acid sequence shown by SEQ ID NO: 61 or the amino acid sequence shown by SEQ ID NO: 61 wherein one or several amino acids are substituted, deleted, inserted and/or added, as well as a means for preventing or treating various diseases involving human ±9 integrin in their pathogenesis, which uses the antibody.
申请公布号 HRP20141110(T1) 申请公布日期 2015.01.16
申请号 HR2014P001110T 申请日期 2014.11.17
申请人 ASTELLAS PHARMA INC. 发明人 UEHARA, KENJI;HIGUCHI, HIROFUMI;NAKASHIMA, TOSHIHIRO;ISHIKAWA, DAISUKE;YAMAMOTO, NOBUCHIKA;FUJITA, HIROTADA;SAKAI, FUMIHIKO
分类号 A61K39/395;A61P29/00;C07K16/28;C07K16/46 主分类号 A61K39/395
代理机构 代理人
主权项
地址